9 minutes | Jun 11th 2018

150 – Venetoclax for CLL; CK0801 for bone marrow failure; 3D printed all-titanium fusion devices; National Youth Tobacco Survey results

June 11, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 0:58 AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy https://www.prnewswire.com/news-releases/abbvie-announces-us-fda-approval-of-venclexta-venetoclax-tablets-in-combination-with-rituximab-as-a-fixed-duration-treatment-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-patients-who-have-received-one-prior--300662514.html  3:10 FDA Clearance of Investigational New Drug Application for CK0801 for Bone Marrow Failure Syndromes https://www.prnewswire.com/news-releases/cellenkos-inc-announces-fda-clearance-of-investigational-new-drug-application-for-ck0801-for-bone-marrow-failure-syndromes-300663808.html 5:17 Centinel Spine Announces 510(k) Clearance of FLX™ Platform of 3D Printed All-Titanium Interbodies https://www.prnewswire.com/news-releases/centinel-spine-announces-510k-clearance-of-flx-platform-of-3d-printed-all-titanium-interbodies-300661595.html 5:59 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610206.htm https://www.natlawreview.com/article/fda-and-cdc-release-results-2017-national-youth-tobacco-survey Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Play
Like
Play Next
Mark
Played
Share